Subscribe to Newsletter

Search

Reset Filter
You have a filtered search result

100 search results for ‘*’

Manufacture Advanced Medicine

The World’s First CRISPR-Based Therapeutic Approval

| Stephanie Vine | 3 min read

It’s official: CRISPR medicines are here as UK authorizes exa-cel.

Discovery & Development Drug Discovery

Opiate Dreams and Nightmares

| Jamie Irvine | 3 min read

Experimental insomnia drug shows promise in alleviating opioid withdrawal symptoms and opioid-seeking behavior

Discovery & Development Drug Discovery

Making Miracles

| 6 min read

After serving as Head of Research Development at Trinity College Dublin, Fiona Killard-Lynch became Director of Research and Innovation at NIBRT

Business & Regulation Standards & Regulation

Nowhere to Hide

| Rob Coker | 2 min read

Never underestimate the meticulousness with which authorities operate or the standards that businesses are expected to adhere to.

Discovery & Development Drug Delivery

Creating CRISPR Chickens

| Jamie Irvine | 4 min read

Researchers genetically modify chickens to build bird-flu resistance – read more here.

Discovery & Development Clinical Trials

Body Positive

| Rob Coker | 2 min read

Almirall’s humanized monoclonal antibody treatment for psoriasis brings positivity for patients

Discovery & Development Drug Discovery

Science Fiction Comes to Life

| Rob Coker | 3 min read

Researchers are working on ways to introduce nanoscale artificial life-forms to viruses with the aim of mimicking the human immune system

Discovery & Development Drug Discovery

New Antibiotic on the Block

| Jamie Irvine | 2 min read

New antibiotic candidate Clovibactin eliminates bacteria without developing resistance

Manufacture Advanced Medicine

The Sickle Cell Solution

| Jamie Irvine

Editas and Azzur Group scale up their efforts against sickle cell disease with experimental gene editing medicine EDIT-301

Discovery & Development Drug Delivery

The Cutting Room Floor

| Jamie Irvine | 2 min read

Scientists are targeting EV-A71 RNA viruses using an adeno-associated virus-delivered CRISPR-Cas13 editor

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register